J Korean Med Sci.  2014 Sep;29(9):1185-1185. 10.3346/jkms.2014.29.9.1185.

Preparedness for Prevention of Ebola Virus Disease

• Hwang ES

• KMID: 1794593
• DOI: http://doi.org/10.3346/jkms.2014.29.9.1185

Abstract

No abstract available.

MeSH Terms

Antiviral Agents/therapeutic use
Hemorrhagic Fever, Ebola/drug therapy/*prevention & control/virology
Humans
Protective Devices
Vaccines/immunology
Antiviral Agents
Vaccines

Reference

1. Hensley LE, Alves DA, Geisbert JB, Fritz EA, Reed C, Larsen T, Geisbert TW. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. J Infect Dis. 2011; 204:S1021–S1031.

2. Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 1983; 61:997–1003.

3. Ebihara H, Rockx B, Marzi A, Feldmann F, Haddock E, Brining D, LaCasse RA, Gardner D, Feldmann H. Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. J Infect Dis. 2011; 204:S991–S999.

4. Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature. 2003; 424:681–684.